Abstract: The embodiments of the present disclosure provide a method and a device for braking a vehicle and a vehicle. After the device for braking a vehicle receives a braking instruction based on V2X, the device for braking a vehicle detects the presence or non-presence of obstacles within a preset safe range by a ranging radar, and if an obstacle is detected within the preset safe range, the braking device is actuated to perform braking. Because the presence or non-presence of obstacles within the preset safe range is detected by the ranging radar mounted on the vehicle prior to making braking, the misjudgment possibility for making braking may be reduced, and thus the technical problem of being dangerous when implementing emergency braking using V2X in the related art is solved.

Abstract: The present disclosure discloses a driver fatigue alert method for a vehicle. The method includes: if a driver fatigue detection device detects driver fatigue information of the present vehicle, then sending the driver fatigue information of the present vehicle to an alert device and a wireless communication device; sending, by the wireless communication device, the driver fatigue information to the outside; and generating, by the alert device, an alert signal according to the driver fatigue information. The present disclosure further discloses a driver fatigue alert system for a vehicle, where the system includes: a driver fatigue detection device; a wireless communication device communicatively connected with the driver fatigue detection device, configured to send driver fatigue information to the outside wirelessly; and an alert device communicatively connected with the driver fatigue detection device and the wireless communication device.

Abstract: The invention discloses a failure alert method for a vehicle, the method including: if a failure detection device of the present vehicle detects failure information of the present vehicle, then sending the failure information of the present vehicle to an alert device and a wireless communication device; sending, by the wireless communication device, the failure information to the outside; and generating, by the alert device, an alert signal according to the received failure information. The invention further disclose a failure alert device for a vehicle, the device including: a failure detection device; a wireless communication device communicatively connected with the failure detection device, configured to send failure information wirelessly to the outside; and an alert device communicatively connected with the failure detection device and the wireless communication device. The invention alleviates in effect a traffic accident from occurring due to the failure of the vehicle.

Abstract: The present disclosure provides a vehicle operation control method, device and system.

Abstract: The present disclosure provides a method and device for determining the distance between vehicles in the Internet of Vehicles.

Abstract: The present disclosure provides a new method for preparing IDO inhibitor epacadostat. The whole reaction route is simple, easy to control and has high yield.

Abstract: A navigating device and a vehicle are disclosed. A V2X communication circuit electrically connected with the navigating unit may be additionally provided in the navigating device; thereby a communication connection with nearby vehicles may be established via V2X communication. Since V2X is a kind of short-range communication, it is possible to perform interactions with nearby vehicle by establishing communication connection with nearby vehicles via V2X communication, and may address the technical problems that the navigating device in the related art have unitary functions and thus cannot perform interaction with nearby vehicles.

Abstract: A liquid crystal panel includes a first substrate, a TFT layer located on the first substrate, a color resist layer located on the TFT layer, a photospacer layer located on the color resist layer, a protective layer located on the color resist layer and the photospacer layer, a via hole penetrating the color resist layer and the protective layer, a pixel electrode layer formed on the protective layer and electrically connected to the TFT layer with the via hole and a second substrate oppositely located to the first substrate, and one or more color resist material in the photospacer layer and the color resist layer are the same, and the photospacer layer and the color resist layer are formed at the same time during a manufacture process.

Abstract: Compounds, compositions and methods useful for treating ocular diseases are provided. In particular, antagonists of TRPV4, their synthesis, pharmaceutical compositions thereof and methods of treating ocular diseases such as glaucoma, are disclosed.

Abstract: A color filter substrate is provided, and includes a glass substrate, a color filter layer and a planar layer. The color filter layers include three color barrier layers and two light-shading layers. Two of the light-shading layers overlap in light-shading regions. A manufacturing method of a color filter substrate is provided, and includes sequentially forming three color barrier layers on a glass substrate, wherein a part of one of a first color barrier layer or a second color barrier layer forms a first light-shading layer, and a part of a third color barrier layer forms a second light-shading layer.

Abstract: Cell culture devices and methods of their use are provided according to aspects of the present invention which include a base having a pair of spaced apart wells and at least one fluid port defined from an exterior of the base to each of the wells, each fluid port being spaced above the base sheet by a distance sufficient to introduce a material above a matrix deposited on the base sheet in the wells; and a cover having a pair of spaced apart well covering portions that are each disposed above a respective one of the one spaced apart wells of the base body when the cover is covering the upper surface of the base body and having a gas passage defined between the spaced apart well covering portions and at least one gas port defined from an exterior of the cover to each of the well covering portions.

Abstract: The present disclosure provides a method for preparing a compound of formula XVII, comprising: (1) contacting a compound of formula XIV with a compound of formula 3 to obtain a compound of formula 2; and (2) contacting the compound of formula 2 with a compound of formula 4 to obtain a compound of formula XVII. The method is low toxicity, cheap, easy to get, environmentally and friendly, and is economical and industrially applicable.

Abstract: A solid dispersion containing Desmodium Styracifolium (Osb.) Merr. flavonoids, method of preparing same and use thereof. The Desmodium Styracifolium (Osb.) Merr. flavonoids are alcohol extract of Desmodium Styracifolium (Osb.) Merr., and the solid dispersion is used for preparing a drug for treating urinary tract calculi.

Abstract: Disclosed is a series of analogues of 4H-pyrazolo[1,5-?]benzimidazole compound as PARP inhibitors. In particular, disclosed in the invention is a compound as shown by formula (I) or a pharmaceutically acceptable salt thereof as a PARP inhibitor.

Abstract: Compounds having activity as PKM2 activators are disclosed. The compounds have the following structure (I): including stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R3, R4, R5 and R6 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

Abstract: The present invention provides protein kinase having one of the following structures (I), (II) or (III): or a stereoisomer, prodrug, tautomer or pharmaceutically acceptable salt thereof, wherein R, R1, R2 and X are as defined herein. Compositions and methods for using the same in the treatment of cancer, autoimmune, inflammatory and other Pim kinase-associated conditions are also disclosed.

Abstract: The present invention provides a liquid crystal display panel and a color film array substrate thereof. The color film substrate comprises a substrate and a black matrix composed on the substrate, a thin film transistor array, a color filter, a pixel electrode, the pixel electrode is stacked and provided on the color filter, the thin film transistor array is stacked and provided on the black matrix as well as connected to the pixel electrode. Through the above way, the present invention does not need to provide CF open on the color filter, avoiding that the gas accommodated in the CF open leaks to the liquid crystal layer and generates bubbles, ensuring the good display effect; moreover, it can raise the encasing alignment accuracy and improve the pixel aperture ratio.

Abstract: A method for controlling a power generation system connected to a weak grid may generally include operating a power converter of the system so as to produce current at or above a power factor threshold associated with a power factor operating requirement for the system, detecting that a generator speed of the system has increased over a period of time, detecting that a local reference voltage for the system has decreased within the same period of time over which the generator speed has increased and adjusting the operation of the power converter to produce current at a reduced power factor below the power factor threshold so as to increase a real power output of the system.

Abstract: The present disclosure provides a new process for preparing PI3K inhibitor buparsilib. The whole reaction route of the present invention is simple and easy to control for the industrial production.

Abstract: Disclosed are a pharmaceutical composition, a method for preparing the same and use thereof. The pharmaceutical composition consists of total flavonoids of Desmodium Styracifolium as an active ingredient and a pharmaceutically acceptable excipient. The pharmaceutical composition can be formulated in a form of a medicament formulation suitable to administration in clinic, and can be used in preparation of clinic treatment medicaments for treating dampness-heat and urinary stone (stagnation of dampness-heat).